Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial
March 16, 2023 09:45 ET
|
Oculis SA
Completed enrollment in Phase 3 OPTIMIZE trial brings OCS-01 one step further on the regulatory path to approval.If approved, OCS-01 has the potential to become the first once-daily, topical,...